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ABSTRACT 
Objective: Alginate beads are not soluble in the acid leading to small portion released in the stomach. This may not be favourable for drugs 
administered for fast action like paracetamol. So, this study was aimed to increase the immediate release of paracetamol from alginate beads, i.e. the 
release in the acidic pH. 
Methods: The beads were prepared by dropwise paracetamol/alginate suspension in divalent cation solution. Two attempts were used to increase 
the dissolution of paracetamol in the acidic pH. First attempt was by only changing preparation variables: needle size, alginate viscosity and drug 
loading using 23 full factorial design. The second approach was by adding excipients like carbopol, tween and polyethylene glycol. The beads were 
characterized for their size, encapsulation efficiency and release profile. 
Results: First approach, changing preparation variables without excipient adding, helped to increase the drug release in the acid but to a maximum 
of 26% using a smaller needle, lower drug loading and higher alginate viscosity. However, optimising the formulation with suitable excipients 
increased the drug release in the acid to 77.3%. The optimised formulation included carbopol 940 (pH sensitive polymer) and tween 80 (facilitates 
water entry) in the beads, with using barium chloride instead of calcium chloride together with PEG 400 in the complexing solution.  
Conclusion: To achieve immediate release of paracetamol from alginate beads in the acidic pH, excipients need to be added. Rational selection of 
excipients is critical to achieve the desired drug release. 
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INTRODUCTION  
The field of natural polysaccharides of marine origin is already large 
and expanding for the biomedical purpose. Alginate is one of the 
marine polysaccharides extracted from seaweeds and it is quite 
abundant in marine brown algae (Phaeophyceae). Other source of 
alginate is bacteria, where it is produced by only two types of 
bacterial genera: Pseudomonas and Azotobacter [1]. The alginic acid 
obtained can then be converted into a salt such as sodium alginate 
which is the major form currently used [2]. The favorable properties 
of alginates like biocompatibility, non-toxicity and ease of gelation 
led to their wide use in food and pharmaceutical industries as tablet 
disintegrant, thickening, and suspending agent, but the interest 
increased toward alginate gel beads as controlled-release devices for 
conventional drugs, proteins, microbial and biological cells [3].  
Alginates are heteropolymer carboxylic acids linked by 1,4-
glycosidic bonds of p-D-mannuronic (M) and a-L-guluronic acid (G) 
units [4]. The most important feature of alginate’s physical 
properties is the selective binding of multivalent cations that is the 
basis for gel formation. The gelation occurs by cross-linking of the 
uronic acid units with divalent cations to form the so-called 'egg-
box' structure. Alginate’s affinity is different toward the various 
divalent ions [5]. Calcium is the most used cation in the preparation 
of alginate beads [4]. Alginates isolated from different sources can 
vary both in monomer composition and block arrangement and 
these variations are also reflected in the properties of the alginate. 
Alginates with a high content of guluronic acid blocks give gels of 
considerably higher strength compared to alginates rich in 
mannuronate, as the G residues exhibit a stronger affinity for 
divalent ions than the M residues. Transmittancy, swelling, and 
viscoelasticity of alginate gel membranes are highly affected by the 
M/G ratio. The stiffness of alginate solution increases when the 
chain blocks increased in the order MG<MM<GG and when the 
molecular weight increases with increasing chain extension [6]. 
The nature of the crosslinking ion and cross-linking conditions such as 
gelation time and concentration of the divalent cation will affect the 
permeability of alginate gels and release the drugs from the beads [7]. 
Another factor also having an impact on alginate beads behaviour is 
the pH of the environment. The beads will stay for nearly 1–4 h in the 
stomach prior to their entry to the small intestine and then to the 
colon. The stay of beads in the highly acidic environment of the 
stomach may result in the hydrolysis of alginate into more soluble low 
molecular weight alginic acid. This causes a reduction in their 
mechanical strength and degree of crosslinking hence the beads may 
degrade at a faster rate after arriving at the colon[8]. In general, the 
properties of gel-forming depend on the monomeric composition, 
block structure, molecular size, concentration of polymer and the type 
of divalent metal ion [9].  
Drug release from alginate beads depends on the swelling of the beads 
and the diffusion of the drug in the gel matrix. However, the alginate 
beads do not swell appreciably in acidic fluid while swell and 
disintegrate rapidly in the intestinal fluid leading to be convenient as 
delayed release formulation but not as immediate release one. Other 
materials (excipients) may need to be added to modulate the ‘original’ 
delayed release from the beads if the immediate release is required. A 
large number of factors including the chemical-physical properties of 
the raw materials (both drug and excipients) and the relative amounts 
of the components in the formulation can influence the drug release 
behavior from the final products [10]. 
Paracetamol has antipyretic, analgesic and weak anti-inflammatory 
actions[11]. It is sparingly soluble in water and prone to dissolution 
and bioavailability problems. Suspension dosage form of paracetamol 
may enhance this problem if properly formulated [12]. Paracetamol is 
not a classic biowaiver because it is classified as a BCS class III but it 
possesses properties borderline to Class I because the permeability is 
slightly below the cut-off value of 90%, i.e. one study found 
permeability to be 80% once absorbed. This enables it to fulfil the 
requirements of a biowaiver [13] so the dissolution profile can be used 
to evaluate the in-vitro drug release profile. Paracetamol has a bitter 
taste and this taste is difficult to be masked in the liquid formulations 
like syrup and suspension. Encapsulation technologies are among 
several techniques to mask the bitter taste of drugs [14]. This study 
was conducted to encapsulate paracetamol in alginate beads so that 
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later the beads can be used for taste masking. However, taste masking 
should not interfere with the drug release. High amount of immediate 
or burst release is required in many cases like pain relief or for some 
antibiotics like gentamicin formulated in microparticles [15]. Because 
alginate beads naturally produce delayed release beads, this study 
aimed to encapsulate paracetamol in alginate beads and enhance the 
drug release in the acidic environment so that the drug can give faster 
onset of action. At first, to increase the drug release in the acid, a 
method without adding excipients was attempted then another 
method was also attempted by adding some excipients. This study 
helps in understanding the effect of the formulation parameters and 
composition on the release of paracetamol in the acidic environment. 
MATERIALS AND METHODS 
Chemicals and reagents 
Pharmaceutical grade paracetamol was obtained from Zhengjiang 
Kangle Pharmaceutical Co., Ltd. (Wenzhou, China). Sodium alginates 
of two viscosity grades noted here as high viscosity (896.44 mPa. s) 
and low viscosity (264.87 mPa. s) were kindly offered from 
FMC Biopolymers (Philadelphia, USA). Calcium chloride and Tween 
80 were obtained from Merck KgaA (Darmstadt, Germany). Other 
materials were of analytical grade. 
Methods 
Preparation of paracetamol alginate beads  
Paracetamol was mixed with sodium alginate solution with the aid 
of sonicator probe. The beads were prepared simply by dropwise 
paracetamol/alginate suspension in divalent cation solution using 
syringe needle with stirring; the stirring was continued for 
approximately 5 min till the bead completely gelled then the beads 
were harvested by filtration, washed with distilled water and air-
dried for 15 min. 
Optimisation of the beads without excipient addition 
The first approach to increase the release of paracetamol from 
alginate beads was changing some processing variables or the type 
of the ingredients without adding any new excipient. This is 
preferred, if successful because it reduces the number of excipients 
in the formulation and hence reducing the cost and complexity. 
Consequently, a total of 8 experiments was conducted to test 3 
different parameters, namely: needle size, alginate viscosity grade 
and paracetamol loading as shown in table 1. The experimental 
design followed 23 full factorial design. 
Optimisation of the beads with excipient addition 
In another approach, the release of paracetamol from alginate beads 
was attempted by the addition of different excipients. These 
excipients change the complex of alginate (barium instead of calcium 
ions), change the viscosity in the acid (carbopol 940) or help in the 
water penetration into the beads such as Tween 80 and 
polyethylene glycol 400 (PEG 400). Four different formulations were 
prepared as presented in table 2.  
Characterization of the beads 
The aim of this study is to optimize the release of paracetamol thus 
only basic characterization was performed on the beads. The bead 
size was measured using Vernier caliper on 10 beads. The 
encapsulation efficacy was estimated by quantifying the un-
encapsulated paracetamol in the calcium solution post-fabrication 
using spectrophotometer at 243 nm. 
Release profile of paracetamol 
An accurately weighed amount of alginate beads equivalent to 34.7 mg of 
paracetamol was added into 125 ml of HCl buffer pH 1.2 in conical flasks 
and introduced into incubator shaker (Innova 4000; New Brunswick 
Scientific Inc., Edison, NJ) with stirring at 100 rpm and temperature at 37 
°C for two h. At scheduled intervals (15 min, 20 min, 30 min, 45 min, 1h 
and 2h), 3-ml samples were taken and an equivalent volume of the fresh 
dissolution medium was added to keep the volume of release medium in 
the flask constant at 125 ml and the amount of drug released was 
determined spectrophotometrically at 243 nm using Hitachi 
spectrophotometer model U-1900 (Hitachi, Tokyo, Japan). After 2 h time, 
the beads were transferred into 125 ml phosphate buffer pH 6.8 and the 
release profile was evaluated similarly.  
RESULTS AND DISCUSSION 
Paracetamol is usually given to the pediatric to lower the temperature 
and/or relief the pain. Therefore, it is aimed to give the action rapidly. 
One inherited issue with sodium alginate beads is that they tend to 
shrink in the acid environment and do not release the encapsulated 
material. The reason behind that is that sodium alginate is insoluble in 
acidic solution while soluble in alkaline solutions so when the calcium 
alginate beads is in an acidic environment (HCl buffer), paracetamol 
releases slowly. The protonation of the carboxylate groups in an acidic 
environment reduced the electrostatic repulsions between alginate 
chains and led to shrinking of the beads and reduce paracetamol release 
[4]. So, this study is trying to increase the release percentage of 
paracetamol from the alginate beads in the acid environment of the 
stomach. To reduce the cost and complexity of the beads, the first 
approach was changing some processing variables or the type of the 
ingredients but not introducing any new material. The variables were 
testing using factorial design which is common experimental design in 
formulation optimization [16, 17]. The size for the beads was 
dependent only on the needle size. Needle of 18G produced beads of 
size 1.81±0.05 mm whereas the 22G needle produced beads of size 
1.28±0.06 mm. Both are larger than the external diameter of the 
needle (18G: 1.27 mm, 22G: 0.71 mm). This is attributed to the 
surface tension of the paracetamol-alginate suspension. Where there 
is no other mean to reduce the surface tension or pull the drop, the 
drop will build on the needle orifice until the weight become equal 
to the surface tension then it falls. 
 
Table 1: Experimental design for optimisation the release of paracetamol without adding excipients, and the release properties of 
paracetamol-alginate beads after 2 h in HCl buffer. The numbers in bracket denote the coding of the factors in the factorial design 
Experiment No./ 
Parameters 
Exp-1 Exp-2 Exp-3 Exp-4 Exp-5 Exp-6 Exp-7 Exp-8 
Needle size (gauge) 18G (1) 22G (2) 22G (2) 22G (2) 22G (2) 18G (1) 18G (1) 18G (1) 
Viscosity of alginate High (2) High (2) Low (1) Low (1) High (2) High (2) Low (1) Low (1) 
Drug loading (g paracetamol/15 ml alginate solution) 5 (2) 5 (2) 1 (1) 5 (2) 1 (1) 1 (1) 1 (1) 5 (2) 
2 h cumulative release (%) HCl buffer  19.3±3.0 23.1±3.3 11.7±0.6 17.7±1.8 18.5±1.5 26.0±4.3 7.2±1.3 14.0±4.7 
 
The release percentage after 2 h in HCl buffer is shown in table 1. 
Factorial analysis as shown in fig. 1 revealed that the effect of 
alginate viscosity and drug loading on drug release in acid were 
significant (p<0.05). All 2-way and 3-way interactions were also 
significant (p<0.05). As shown in fig. 1, alginate viscosity has the 
highest effect on drug release in the acid. The alginate of higher 
viscosity released paracetamol faster than lower viscosity alginate, 
which is an unexpected result. It was expected that higher viscosity 
alginate produces stronger beads and so the release becomes 
slower. However, the higher viscosity alginate may produce non-
homogenous beads due to a strong shell made at the beginning of 
complexation; leading to less calcium in the core. On the other hand, 
lower viscosity alginate allows calcium ions to enter to the core, 
making homogenous beads. This might explain the faster release 
observed by higher viscosity alginate. Higher drug loading resulted 
in higher release (fig. 1). 
Even though the interactions were statistically significant (p<0.05) 
but only the interaction between alginate viscosity and drug loading 
was of important change on the drug release (fig. 1B right panel). 
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When alginate viscosity increased, drug release increased in both 
drug loading values, but the increase was less with the higher drug 
loading (5%). Other interactions showed a slight increase or 
decrease on the drug release as shown in fig. 1B. 
 
 
Fig. 1: Effect of needle size, alginate viscosity and drug loading on the release percentage of paracetamol after 2h in the acid. A: main 
effect, B: interactions. vis: viscosity 
 
The release profile in both HCl buffer and phosphate buffer is presented 
in fig. 2. The release in the acidic environment ranged from 7.2±1.3% 
(Exp-7) to 26.0±4.3% (Exp-6) while the release in the phosphate buffer 
occurred rapidly and all formulations released the total amount of 
paracetamol within 2 h. Actually, all formulations, except for Exp-4 and 
Exp-8, released almost 80% or more within 15 min. The two 
formulations, Exp-4 and Exp-8, released around 57% within 15 min then 
gradually released the remaining amount within 2 h. 
 
 
Fig. 2: Release profile of paracetamol from alginate beads in both HCl and phosphate buffers. Alginate formulations were prepared without 
excipient addition. Refer to table 1 for the parameters in each formulation. Each point represent mean (3 samples)±standard deviation (SD) 
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To sum up, the optimisation without excipient addition helped to 
increase the release of paracetamol in the acidic buffer but only to 26.0% 
of the total encapsulated amount. This may not be sufficient to give the 
desired fast onset of action. Therefore, another approach was attempted 
to increase the release of paracetamol in the acidic environment. This 
approach involves the addition of different excipients as shown in table 2. 
 
Table 2: Experimental design for optimization the release of paracetamol with adding excipients. The ingredients were used in the 
following concentrations/quantities: paracetamol (1g), carbopol 940 (1%), tween 80 (1%), calcium chloride (1%), barium chloride (1%), 
PEG 400 (25%). The preparation was carried out using 22G needle 
Medium Formulation 1 Formulation 2 Formulation 3 Formulation 4 
Paracetamol/alginate suspension  -Paracetamol  
-Sodium alginate 
-Paracetamol  
-Sodium alginate 
-Carbopol 940  
-Tween 80  
-Paracetamol  
-Sodium alginate  
-Carbopol 940 
-Tween 80 
-Paracetamol  
-Sodium alginate  
-Carbopol 940 
-Tween 80 
Divalent cation solution -Calcium chloride  -Barium chloride  -Barium chloride 
-PEG 400 
-Calcium chloride 
-PEG 400  
2 h cumulative release (%) HCl buffer  10.5 26.5 77.3 20.4 
 
The release profiles of paracetamol from the four formulations were 
different as illustrated in fig. 3. The maximum release of paracetamol 
was observed in Formulation 3, which reached about 41% after 15 min 
and increased gradually to 63.7% after one hour and 77.3 % after two 
hours. Meanwhile, the other formulations did not increase the release of 
paracetamol better than the optimisation without excipient addition. 
  
 
Fig. 3: Release profile of paracetamol from alginate beads in HCl buffer. Alginate formulations were prepared with excipient addition. 
Refer to table 2 for the composition of each formulation. Each point represent mean (3 samples)±standard deviation (SD) 
 
In Formulation 2, compared to Formulation 1, the paracetamol-
alginate suspension was enhanced by the addition of Carbopol 940 
and Tween 80 whereas in the divalent solution calcium ions were 
replaced by barium ions. Carbopol 940 is a synthetic crosslinked 
high molecular weight polymer of acrylic acid. It is hygroscopic, 
disperse in water and makes gels when neutralized to pH~6.0. 
However, the viscosity drops considerably in the pH less than 3 [18]. 
This property was the rationale behind the addition of Carbopol to 
the formulation. Carbopol is dissolved with sodium alginate then 
incorporated in the beads. Upon contact with the acidic pH of the 
stomach, the viscosity of carbopol decreases and hence the bead 
structure becomes weaker. Consequently, more entrapped material 
(paracetamol) can release to the medium, contributing to the more 
release observed. Tween 80 is a hydrophilic surfactant, commonly 
used as wetting agent or emulsifier. It may help to allow more water 
and acid to penetrate the beads. It also helps in wetting paracetamol 
particles and facilitates its solubility. Barium ions were shown 
previously to make the beads swell more [5], and this will facilitate 
the release of paracetamol. Previous studies showed that using 
barium ions as crosslinker resulted in the faster release of the 
encapsulated material [19, 20]. All these excipients helped to increase 
the release of paracetamol in the acid by about 2.5 folds. Despite that, 
the release was still less than 30% which is considered low.  
The addition of PEG400 (Formulation 3) to the ionic solution 
resulted in dramatic increase in the release of paracetamol in the 
acid, from 26.5% to 77.3%. PEG 400 is water miscible solvent in all 
proportions. During the complexation, PEG is expected to penetrate 
inside the beads and coat the surface. Then, upon contact with the 
acidic environment, PEG leaks into the medium disturbing the bead 
structure and allowing water to penetrate and paracetamol to 
release. The observed effects of PEG comply with previous studies 
that reported the presence of polyethene glycols in the film coats, 
especially the liquid grades like PEG 400, tended to increase the 
water penetration and reduce the protection of the enteric film coat 
against the acidic pH [18].  
CONCLUSION 
To achieve the immediate release of paracetamol from alginate 
beads in the acidic pH, excipients need to be added. Calcium alginate 
beads are not soluble in the acidic stomach solution leading to a 
small percentage of paracetamol released. The optimisation of drug 
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release by changing variables such as alginate viscosity, needle size 
and drug loading (no excipient is added) failed to increase the 
paracetamol release in the acid more than 26.0±4.3%. Adding 
suitable excipients such as carbopol 940 and tween 80, and using 
barium chloride instead of calcium chloride together with a coating 
with PEG 400 helped to increase the drug release in the acid up to 
77.3%. This increase in drug release in the acidic pH may help to get 
the faster onset of the pharmacological action of paracetamol. 
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